Core Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	114.28	69.71	52.24	131.68
Short-Term Investments	0	2.28	0.72	234.3
Cash & Cash Equivalents	114.28	71.99	52.96	365.98
Cash Growth	64.92%	35.93%	-85.53%	-
Receivables	1.11	1	0.26	1.68
Other Current Assets	27.94	24.02	31.88	388.9
Total Current Assets	143.32	97.02	85.1	756.56
Property, Plant & Equipment	653.74	593.28	711.56	597.3
Goodwill and Intangibles	2.14	2.25	1.7	1,064
Other Long-Term Assets	14.78	19.62	9.32	21.05
Total Long-Term Assets	670.65	615.14	722.58	1,682
Total Assets	813.97	712.16	807.69	2,439
Accounts Payable	16.17	154.75	53.64	11.62
Deferred Revenue	9.25	9.83	78.19	136.36
Current Debt	28.97	144.21	37.01	104.45
Other Current Liabilities	83.76	179.64	17.95	67.86
Total Current Liabilities	138.15	488.42	186.79	320.29
Long-Term Debt	626.77	820.67	1,028	714.36
Other Long-Term Liabilities	367.57	0	2.21	18.53
Total Long-Term Liabilities	994.33	820.67	1,030	732.89
Total Liabilities	1,132	1,309	1,217	1,053
Total Debt	655.74	964.88	1,065	818.81
Debt Growth	-33.63%	-9.40%	30.07%	-
Retained Earnings	-2,209.52	-2,420.24	-2,173.75	-27.43
Comprehensive Income	0	0	0	-10.97
Shareholders' Equity	-318.51	-596.94	-409.35	1,341
Net Cash / Debt	-541.46	-892.89	-1,012.08	-452.83
Net Cash Per Share	-1.92	-2.35	-2.97	-1.94
Working Capital	5.18	-391.41	-101.69	436.27
Book Value Per Share	-1.38	-1.57	-1.20	6.47

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).